{"database":"biostudies-other","file_versions":[],"scores":null,"additional":{"submitter":["Severgnini M"],"pagination":["43-56"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-ECPF-MEXP-232"],"project":["EurocanPlatform"],"abstract":["Evaluation of two commercial microarray platforms (Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A). Both platforms have been tested on gene expression profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 µM resveratrol."],"repository":["biostudies-other"],"experiment_type":["transcription profiling by array"],"data_source":["EurocanPlatform"],"omics_type":["Unknown"],"volume":["353"],"journal":["Analytical biochemistry"],"species":["Homo sapiens"],"pubmed_authors":["Mezzelani A","Peano C","De Bellis G","Viti F","Milanesi L","Bicciato S","Battaglia C","Ghidoni R","Mangano E","Bonnal R","Scarlatti F","Severgnini M","Mattioli M"],"additional_accession":[]},"is_claimable":false,"name":"Platform comparison and transcription profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 ?M resveratrol to evaluate Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A)","description":"Evaluation of two commercial microarray platforms (Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A). Both platforms have been tested on gene expression profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 µM resveratrol.","dates":{"release":"2016-04-14T14:46:23Z","publication":"2006 Jun","modification":"2016-04-14T14:46:23Z","creation":"2016-04-14T14:46:23Z"},"accession":"S-ECPF-MEXP-232","cross_references":{"ArrayExpress":["E-MEXP-232"],"EFO":["EFO_0000305","EFO_0000322"],"ArrayExpress files":["E-MEXP-232"]}}